Last Updated: 05/05/2026

Astrea Bioseparations

Cambridge

Founded 1987

Chromatography resins and bioseparation technologies for biomanufacturing

Astrea Bioseparations develops and manufactures chromatography resins, adsorbents, columns and nanofiber-based purification technologies for the biopharmaceutical and advanced therapeutics industries.

Its portfolio supports downstream bioprocessing including affinity purification, host cell protein removal, viral vector purification and plasmid DNA processing.

Products are used in more than 21 FDA and EMA approved manufacturing processes globally.

Headquartered in Cambridge with manufacturing on the Isle of Man and operations in the US and Singapore.

Reagents & Consumables Cell & Gene Therapy Chemical & Analytical Bioprocessing & Manufacturing

DNA Manufacturing GMP Manufacturing Protein Engineering

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Company Notes

Previously Known As

Prometic Bioseparations

Member of

BioIndustry Association

Similar Companies